GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

INSM · Mar 31, 2026

INSMED Inc. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001104506-26-000032General Corporate
Debt relative to revenue5thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.debt_to_revenue

178.70% · OPTIONAL · VALID

Capex intensity5thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

1.14% · OPTIONAL · VALID

Operating cash generation100thOwn-history percentile · N=20
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-72.80% · OPTIONAL · VALID

Revenue growth100thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.revenue

229.62% · CORE · VALID

Inventory pressure25thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

43.44% · OPTIONAL · VALID

Operating margin100thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.operating_margin

-50.11% · CORE · VALID

R&D intensity0thOwn-history percentile · N=20
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

68.47% · OPTIONAL · VALID

SBC intensity0thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

14.95% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History27 statesSelf-history eligible
Sep 30, 20217/8 normalizedLevel 3Dec 31, 20218/8 normalizedLevel 3Mar 31, 20228/8 normalizedLevel 3Jun 30, 20228/8 normalizedLevel 3Sep 30, 20228/8 normalizedLevel 3Dec 31, 20228/8 normalizedLevel 3Mar 31, 20238/8 normalizedLevel 3Jun 30, 20238/8 normalizedLevel 3Sep 30, 20238/8 normalizedLevel 3Dec 31, 20238/8 normalizedLevel 3Mar 31, 20248/8 normalizedLevel 3Jun 30, 20248/8 normalizedLevel 3Sep 30, 20248/8 normalizedLevel 3Dec 31, 20248/8 normalizedLevel 3Mar 31, 20258/8 normalizedLevel 3Jun 30, 20258/8 normalizedLevel 3Sep 30, 20258/8 normalizedLevel 3Dec 31, 20258/8 normalizedLevel 3Mar 31, 20268/8 normalizedLevel 3Jun 30, 20268/8 normalizedLevel 4
Period transition

What moved in the state?

Balance Sheet Leverage Increased
Previous
90.16%
Current
178.70%
Delta
88.54%
Capex Intensity Decreased
Previous
5.37%
Current
1.14%
Delta
-4.23%
Cash Generation Increased
Previous
-154.19%
Current
-72.80%
Delta
81.39%
Growth Increased
Previous
66.73%
Current
229.62%
Delta
162.89%
Inventory Pressure Increased
Previous
21.78%
Current
43.44%
Delta
21.66%
Profitability Increased
Previous
-205.59%
Current
-50.11%
Delta
155.48%
R And D Intensity Decreased
Previous
127.15%
Current
68.47%
Delta
-58.69%
Sbc Intensity Decreased
Previous
25.18%
Current
14.95%
Delta
-10.23%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Analogous To · INSM state analogue 1 →Has State · INSMED Inc →Transitioned To · INSM Fundamental State →Transitioned To · INSM BALANCE_SHEET_LEVERAGE_INCREASED →Transitioned To · INSM CAPEX_INTENSITY_DECREASED →Transitioned To · INSM CASH_GENERATION_INCREASED →Transitioned To · INSM GROWTH_INCREASED →Transitioned To · INSM INVENTORY_PRESSURE_INCREASED →Transitioned To · INSM PROFITABILITY_INCREASED →Transitioned To · INSM R_AND_D_INTENSITY_DECREASED →Transitioned To · INSM SBC_INTENSITY_DECREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.